Search

Your search keyword '"Arcioni, Francesco"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Arcioni, Francesco" Remove constraint Author: "Arcioni, Francesco"
46 results on '"Arcioni, Francesco"'

Search Results

4. Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes

6. Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy

7. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection

8. Real-World Data on the Occurrence of Vaso-Occlusive Crises (VOCs) in Patients with Sickle Cell Disease (SCD) and a High Baseline Disease Burden Treated with Crizanlizumab: Results from a Managed Access Program (MAP)

10. Case Report: Remdesivir and Convalescent Plasma in a Newly Acute B Lymphoblastic Leukemia Diagnosis With Concomitant Sars-CoV-2 Infection

11. HLA-Haploidentical Transplantation with Regulatory and Conventional T-Cells Adoptive Immunotherapy in Pediatric Patients with High-Risk Acute Leukemia

12. Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study

13. HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype‐phenotype correlation

14. Acute events in children with sickle cell disease in Italy during the COVID‐19 pandemic: useful lessons learned.

15. Targeted Therapy with Sirolimus and Nivolumab in a Child with Refractory Multifocal Anaplastic Ependymoma.

16. Acute Chest Syndrome in Children with Sickle Cell Disease in Italy: Results of a National Survey from the Italian Association of Pediatric Hematology Oncology (AIEOP)

17. Retrospective and Prospective Study of Childhood Autoimmune Hemolytic Anemia. a Preliminary Report from the Red Cell Working Group of the Paediatric Hemato-Oncology Italian Associations (AIEOP)

18. 279 - HLA-Haploidentical Transplantation with Regulatory and Conventional T-Cells Adoptive Immunotherapy in Pediatric Patients with High-Risk Acute Leukemia

19. HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype‐phenotype correlation.

20. Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey

22. Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?

23. Sirolimus-Based Immunosuppression as GvHD Prophylaxis after Bone Marrow Transplantation for Severe Aplastic Anaemia: A Case Report and Review of the Literature

24. The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy

25. Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?

26. Use of Lenalidomide in DEL(5q) MDS. a National AIFA (Agenzia Italiana del Farmaco) Registry Study

27. The Hereditary Hyperferritinemia-Cataract Syndrome in 2 Italian Families

28. Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency.

30. Prospective changes of cardiac iron and function in low and intermediate-1 risk mds patients

31. Prospective Changes of Cardiac and Hepatic Iron and Cardiac Function in Low and Intermediate-1 Risk MDS Patients

33. Wernicke Encephalopathy in Pediatric Neuro-oncology

34. Myocardial Tissue Characterization By Cardiac MR Imaging In Myelodysplastic Syndromes

35. MRI Survey In Transfusion-Dependent and Non-Transfusion-Dependent MDS Patients

36. Lenalidomide in Myelodysplastic Syndromes with 5q Deletion. Results From the Italian National Cancer Registry

37. NPM1 Deletion Is Associated with Gross Chromosomal Rearrangements in Leukemia

38. NPM1 Deletion Is Associated with Gross Chromosomal Rearrangements in Leukemia.

39. Real‐World Evidence of Crizanlizumab Showing Reductions in Vaso‐Occlusive Crises and Opioid Usage in Sickle Cell Disease.

40. Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study.

41. Extracorporeal Photopheresis (ECP) as first-line Treatment for Acute GVHD (AGVHD) in Pediatric Patients who underwent T-depleted Haploidentical Stem Cell Transplantation (APLO-HSCT)

42. Wernicke Encephalopathy in Pediatric Neuro-oncology: Presentation of 2 Cases and Review of Literature.

43. Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy

44. Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection

45. Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.

46. Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?

Catalog

Books, media, physical & digital resources